These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2636292)

  • 21. [Clinical experience in Hurthle cell tumors].
    Francomano F; Napolitano L; Scipione P; Savini F; Bajocchi G; Angelucci D
    G Chir; 1998; 19(11-12):449-52. PubMed ID: 9882947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hurthle cell tumors of the thyroid gland.
    Miller RH; Estrada R; Sneed WF; Mace ML
    Laryngoscope; 1983 Jul; 93(7):884-8. PubMed ID: 6865624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hürthle cell lesions of the thyroid gland.
    Thompson NW; Dunn EL; Batsakis JG; Nishiyama RH
    Surg Gynecol Obstet; 1974 Oct; 139(4):555-60. PubMed ID: 4479589
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hürthle cell tumor of the thyroid gland. Analysis of a series of 33 cases].
    Janser JC; Pusel J; Rodier JF; Navarrete E; Rodier D
    J Chir (Paris); 1989 Nov; 126(11):619-24. PubMed ID: 2685000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oncocytoma of the thyroid gland].
    Burkhard B; Bartl G; Alber G; Harlass G; Schwarzfischer P
    Fortschr Med; 1981 Aug; 99(30):1183-8. PubMed ID: 7274932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [So-called oncocytoma of the thyroid (author's transl)].
    Florack G; Sailer R; van der Horst W
    Dtsch Med Wochenschr; 1980 Jul; 105(28):983-7. PubMed ID: 7408693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy?
    McHenry CR; Thomas SR; Slusarczyk SJ; Khiyami A
    Surgery; 1999 Oct; 126(4):798-802; discussion 802-4. PubMed ID: 10520931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of accordance between cytological and histopathological findings in selected thyroid tumors].
    Gołkowski F; Jabrocka A; Huszno B; Trofimiuk M; Buziak-Bereza M; Kulig J; Cichoń S
    Przegl Lek; 2004; 61(1):10-2. PubMed ID: 15230098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria.
    Renshaw AA
    Cancer; 2002 Oct; 96(5):261-6. PubMed ID: 12378592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid disorders. Part III: neoplastic thyroid disease.
    Little JW
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):275-80. PubMed ID: 16920533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
    Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fine-needle aspiration biopsy specimen with a predominance of Hürthle cells: a dilemma in the management of nodular thyroid disease.
    Alaedeen DI; Khiyami A; McHenry CR
    Surgery; 2005 Oct; 138(4):650-6; discussion 656-7. PubMed ID: 16269293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oncocytic tumors of the thyroid gland. Giant cell adenoma of the thyroid gland; Hürthle cell tumor].
    van Kaick G
    Med Welt; 1970 Apr; 15():668-71. PubMed ID: 5523241
    [No Abstract]   [Full Text] [Related]  

  • 34. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fine-needle aspiration cytology of Hürthle cell carcinoma of the thyroid.
    Wu HH; Clouse J; Ren R
    Diagn Cytopathol; 2008 Mar; 36(3):149-54. PubMed ID: 18232004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hürthle cell tumor of the thyroid: which surgical approach?].
    Favia G; Annunziata N; Dalla Palma F; D'Amico C; Lumachi F; De Battisti S; Scarpa V
    G Chir; 1989 Apr; 10(4):163-6. PubMed ID: 2518548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Follicular thyroid gland cancer (differential diagnosis of follicular adenoma)].
    Veselov VA
    Arkh Patol; 1981; 43(2):33-8. PubMed ID: 7224878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spindle and giant cell carcinoma of the thyroid: cytologic diagnosis by fine needle aspiration.
    Schneider V; Frable WJ
    Acta Cytol; 1980; 24(3):184-9. PubMed ID: 6931462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic role of markers dipeptidyl peptidase IV and thyroid peroxidase in thyroid tumors.
    Kholová I; Ludvíkova M; Ryska A; Topolcan O; Pikner R; Pecen L; Cáp J; Holubec L
    Anticancer Res; 2003; 23(2A):871-5. PubMed ID: 12820316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hürthle cell tumors: personal experience].
    De Toma G; Gabriele R; Sgarzini G; Plocco M; Campli M; Sambuco L
    G Chir; 1995 May; 16(5):223-6. PubMed ID: 7654499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.